APA (7th ed.) Citation

Yanai, K., Hirai, K., Kitano, T., Miyazawa, H., Ito, K., Ookawara, S., & Morishita, Y. (2025). Systolic blood pressure is associated with early and long-term changes in renal function in patients with dapagliflozin-treated moderate-to-advanced chronic kidney disease. Clinical and Experimental Nephrology: Official Publication of the Japanese Society of Nephrology, 1-12. https://doi.org/10.1007/s10157-025-02678-9

Chicago Style (17th ed.) Citation

Yanai, Katsunori, Keiji Hirai, Taisuke Kitano, Haruhisa Miyazawa, Kiyonori Ito, Susumu Ookawara, and Yoshiyuki Morishita. "Systolic Blood Pressure Is Associated with Early and Long-term Changes in Renal Function in Patients with Dapagliflozin-treated Moderate-to-advanced Chronic Kidney Disease." Clinical and Experimental Nephrology: Official Publication of the Japanese Society of Nephrology 2025: 1-12. https://doi.org/10.1007/s10157-025-02678-9.

MLA (9th ed.) Citation

Yanai, Katsunori, et al. "Systolic Blood Pressure Is Associated with Early and Long-term Changes in Renal Function in Patients with Dapagliflozin-treated Moderate-to-advanced Chronic Kidney Disease." Clinical and Experimental Nephrology: Official Publication of the Japanese Society of Nephrology, 2025, pp. 1-12, https://doi.org/10.1007/s10157-025-02678-9.